How severe is CVE-2024-1706?

CVE-2024-1706 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.

Is CVE-2024-1706 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (35th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-1706?

CVE-2024-1706 affects Zkteco Zkbio Access Ivs. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-1706?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-1706 have an EU (EUVD) identifier?

Yes. CVE-2024-1706 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-17440.

When was CVE-2024-1706 published?

CVE-2024-1706 was published on 2024-02-21 and last updated on 2026-06-17.

CVE-2024-1706

CVE-2024-1706 is a low-severity vulnerability in Zkteco Zkbio Access Ivs with a CVSS 3.x base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Low (CVSS 3.x base score 3.5)
CVSS v2: 4.0
CVSS v4: 2.0
EPSS exploit prediction: 0% (35th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-17440
Weakness: CWE-79
Affected product: Zkteco Zkbio Access Ivs
Published: 2024-02-21
Last modified: 2026-06-17

Description

A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input <marquee>hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer.

Frequently asked questions

What is CVE-2024-1706?: A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input <marquee>hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer.
How severe is CVE-2024-1706?: CVE-2024-1706 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2024-1706 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (35th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-1706?: CVE-2024-1706 affects Zkteco Zkbio Access Ivs. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-1706?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-1706 have an EU (EUVD) identifier?: Yes. CVE-2024-1706 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-17440.
When was CVE-2024-1706 published?: CVE-2024-1706 was published on 2024-02-21 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:zkteco:zkbio_access_ivs:*:*:*:*:*:*:*:*

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →